... HIV/AIDS Reports
Weight Gain on HIV Treatment: More Common With Newer Drugs, Low CD4 Counts — NAM aidsmap ...
... — HIVinfo.NIH.gov
Neurological Complications of HIV — John Hopkins Medicine
HIV-1 Associated Opportunistic Infections — StatPearls
Global HIV Neurology: A Comprehensive Review — AIDS
Headaches — Cleveland Clinic
HIV Pain Management Challenges and Alternative Therapies — Nursing 2023 ...
Dolores de cabeza y VIH: 7 causas para considerar
... — HIVinfo.NIH.gov
Neurological Complications of HIV — John Hopkins Medicine
HIV-1 Associated Opportunistic Infections — StatPearls
Global HIV Neurology: A Comprehensive Review — AIDS
Headaches — Cleveland Clinic
HIV Pain Management Challenges and Alternative Therapies — Nursing 2023 ...
... Virgin Islands, 2014 — Centros para el Control y la Prevención de Enfermedades (CDC)
Indetectable = intransmisible — Centro Nacional para la Prevención y el Control del VIH y el sida, Gobierno de México
Examen de sangre ELISA — MedlinePlus
Getting Tested for HIV — Centros para el Control y la Prevención de Enfermedades (CDC)
...
¿El VIH puede detectarse en cualquier análisis de sangre?
... Virgin Islands, 2014 — Centros para el Control y la Prevención de Enfermedades (CDC)
Indetectable = intransmisible — Centro Nacional para la Prevención y el Control del VIH y el sida, Gobierno de México
Examen de sangre ELISA — MedlinePlus
Getting Tested for HIV — Centros para el Control y la Prevención de Enfermedades (CDC)
...
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
VIH-1 frente a VIH-2: ¿Cuáles son las diferencias y puede tener ambas?
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
CBD para el VIH: ¿es eficaz?
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
... : United States 2008-2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral Hepatitis
Epidemiological Trends of HIV/HCV Coinfection in Spain, 2015 ...
Envejecer con VIH: 5 problemas que debe vigilar
... : United States 2008-2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral Hepatitis
Epidemiological Trends of HIV/HCV Coinfection in Spain, 2015 ...
... Referencias
Switch to Single-Tablet Bictegravir-Lenacapavir From a Complex HIV Regimen (Artistry-1): A Randomised, Open-Label, Phase 3 Clinical Trial — The Lancet
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy — Gilead
...
... Centers for Disease Control and Prevention
La OMS recomienda el lenacapavir inyectable para la prevención del VIH — Organización Mundial de la Salud
...
... Control and Prevention
Measurement of Human Immunodeficiency Virus P24 Antigen — Clinical Infectious Diseases
Estimating Per-Act HIV Transmission Risk: A Systematic Review — AIDS ...
únete
Tus opciones de privacidad
